Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a Randomized Controlled Trial: a Quality of Life Study in Cancer Survivors

NCT06711978 is registered in ClinicalTrials.gov with Pusan National University Yangsan Hospital as lead sponsor.

NCT NCT06711978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06711978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a Randomized Controlled Trial: a Quality of Life Study in Cancer Survivors
Lead sponsor
Pusan National University Yangsan Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2024
Completion date
April 15, 2026
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cipn, cipn - chemotherapy-induced peripheral neuropathy, cipn in adjuvant breast cancer patients, duloxetine, mirogabalin